Editorial: Understanding How Social Determinants of Health Impact Mortality in MASLD-Insights From a National Analysis. Authors' Reply [0.03%]
组稿：社会因素对MASLD患者死亡率影响的国家分析——作者回信
Donghee Kim,Pojsakorn Danpanichkul,Karn Wijarnpreecha et al.
Donghee Kim et al.
Editorial: Mitigating the Risk of Adverse Pregnancy Outcomes in Women With Inflammatory Bowel Disease and Chronic Liver Disease-Authors' Reply [0.03%]
关于炎症性肠病和慢性肝病女性不良妊娠结局的风险的 Editorial-作者回复
Jessica D Lee,Konstantinos Papamichael,Lauren T Grinspan et al.
Jessica D Lee et al.
Editorial: Mitigating the Risk of Adverse Pregnancy Outcomes in Women With Inflammatory Bowel Disease and Chronic Liver Disease [0.03%]
论著：炎症性肠病和慢性肝病女性的不良妊娠结局的风险防控
Yooyun Chung,Jeremy Shanika Nayagam
Yooyun Chung
Gastrointestinal Cancer Risk in Steatotic Liver Diseases: MASLD, MetALD and ALD [0.03%]
肝脂变性疾病中的胃肠道癌症风险：MASLD、MetALD 和 ALD
Nobuharu Tamaki,Takefumi Kimura,Shun-Ichi Wakabayashi et al.
Nobuharu Tamaki et al.
Background: Steatotic liver disease (SLD), which encompasses metabolic dysfunction-associated SLD (MASLD), MASLD with increased alcohol intake (MetALD) and alcohol-associated liver disease (ALD), is recognised as a risk f...
Meta-Analysis: Liver Disease Burden and Associated Factors in Turner Syndrome [0.03%]
Turner综合征肝病负担及影响因素的meta分析研究
Mohamad Jamalinia,Fatemeh Zare,Alessandro Mantovani et al.
Mohamad Jamalinia et al.
Background: The prevalence, incidence, and associated factors of liver disease (LD) in Turner syndrome (TS) remain uncertain. Aims: A m...
Review Article: Extending the Frontiers of Intestinal Ultrasound Knowledge, Performance and Expansion [0.03%]
肠道超声的前沿扩展：知识、表现和应用
Cathy Lu,Bram Verstockt,Michael W Winter et al.
Cathy Lu et al.
Background: Intestinal ultrasonography (IUS) is increasingly utilised for diagnosing and monitoring IBD. Despite its cost-effectiveness, patient tolerance and suitability for serial bedside assessments, broad adoption has...
Letter: Methodological Caveats in Zhang et al.-Gut Microbiota and Metabolism in Cirrhotic Portal Hypertension [0.03%]
来信：张等关于门脉高压症患者肠道菌群和代谢的研究之方法学局限性
Muhammad Talha Ghaffar
Muhammad Talha Ghaffar
Letter: From Descriptive Epidemiology to Clinical Imperative-Challenging the Paradigm of Pain and Sedative Use in Inflammatory Bowel Disease. Authors' Reply [0.03%]
来信：从描述性流行病学到临床要求——挑战炎症性肠病中疼痛和镇静药使用的范式。作者回复
Samantha Baillie,Jonathan Blackwell,Richard Pollok
Samantha Baillie
Letter: From Descriptive Epidemiology to Clinical Imperative-Challenging the Paradigm of Pain and Sedative Use in Inflammatory Bowel Disease [0.03%]
致编辑的信：从描述性流行病学到临床要求——挑战炎症性肠病中的疼痛和镇静药使用的范式
DuJiang Yang,Jiexiang Yang,Shuang Wang et al.
DuJiang Yang et al.
Editorial: Comparable Hepatic Fibrosis Risk Demands Equal Vigilance in Lean and Non-Lean Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease [0.03%]
论点：对于患有代谢异常相关肝硬化疾病的 lean 和非 lean 患者而言，可比较的肝脏纤维化风险要求同等的关注度
Shinya Yokoyama,Takanori Ito
Shinya Yokoyama